Trueblood Wealth Management’s IBM IBM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Sell
3,922
-137
-3% -$34.5K 0.39% 85
2026
Q1
$984K Sell
4,059
-398
-9% -$108K 0.38% 85
2025
Q4
$1.32M Buy
4,457
+142
+3% +$42.5K 0.52% 63
2025
Q3
$1.22M Buy
4,315
+469
+12% +$123K 0.47% 71
2025
Q2
$1.13M Buy
3,846
+204
+6% +$52.6K 0.47% 70
2025
Q1
$906K Buy
3,642
+355
+11% +$86.8K 0.42% 83
2024
Q4
$722K Buy
3,287
+519
+19% +$116K 0.36% 96
2024
Q3
$612K Buy
2,768
+100
+4% +$19.6K 0.31% 104
2024
Q2
$461K Buy
2,668
+568
+27% +$98.7K 0.26% 116
2024
Q1
$401K Buy
2,100
+710
+51% +$130K 0.23% 124
2023
Q4
$227K Buy
+1,390
New +$210K 0.14% 183

Other funds holding IBM

Trueblood Wealth Management's IBM Position: Q2 2026 in Review

Trueblood Wealth Management reduced its IBM (IBM) stake by 3.4% in Q2 2026, selling an estimated $34.5K and leaving 3,922 shares worth $1.1M. The position accounts for 0.39% of the portfolio, ranked #85.

Trueblood Wealth Management first reported a position in IBM in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.32M in Q4 2025. 1,810 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

  • Trueblood Wealth Management held 3,922 shares of IBM worth $1.1M as of Q2 2026.
  • Trueblood Wealth Management sold 137 IBM shares in Q2 2026, an estimated $34.5K.
  • IBM made up 0.39% of Trueblood Wealth Management's portfolio in Q2 2026, its #85 holding.
  • Trueblood Wealth Management first reported a position in IBM in Q4 2023 and has held it in 11 quarters since.
  • Trueblood Wealth Management's IBM position peaked at $1.32M in Q4 2025.
  • 1,810 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.